Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-02-08

Clinical Trial Update: A Safety and Tolerability Study of Arformoterol Tartrate Inhalation Solution in Pediatric Subjects [Phase 2]

View source ↗

Summary

Phase 2 safety and tolerability trial of arformoterol tartrate inhalation solution in pediatric subjects with asthma. Results were posted in 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ARFORMOTEROL TARTRATE INHALATION SOLUTION (arformoterol tartrate inhalation solution)

Snippet

Sponsor: Sumitomo Pharma America, Inc. | Conditions: Asthma | Phase 2 | Status: COMPLETED | Results posted: 2010-02-08